Nur (NURI) AI Stock Analysis

• Market Cap: ₪79.12M
• Dividend Yield: N/A
• Average Volume (3M): 6.96K
• Price to Earnings (P/E): ―
• Beta (1Y): 0.77
• Revenue Growth: N/A
• EPS Growth: N/A
• Country: IL
• Employees: 15
• Sector: Technology
• Sector Strength: 88
• Industry: Chemicals - Specialty
• EPS (TTM): -72.70
• Shares Outstanding: 7,659,280
• 10 Day Avg. Volume: 4,577
• 30 Day Avg. Volume: 6,963
• PEG Ratio: 0.15
• Price to Book (P/B): 3.50
• Price to Sales (P/S): 177.22
• P/FCF Ratio: -6.29
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 50 Neutral
• Price Target: 1,317.00 ▼(-1.13% Downside)
• Action: Reiterated Date: 01/06/26
• Date: Action: Reiterated 01/06/26

Score is held back primarily by weak financial performance (deep losses and significant cash burn), partially offset by strong technical uptrend signals. Valuation provides limited support due to a negative P/E and no dividend yield data.

Positive Factors

Low leverage / balance-sheet flexibility

Low reported leverage and positive equity give the company structural financial flexibility. With modest debt relative to equity, the firm is better positioned to absorb ongoing losses, access additional financing, and fund operational or strategic investments over the next several months.

Initial revenue traction

Revenue appearing in 2024 after years of zero demonstrates the business has begun commercial activity. While the base is small, sustained top-line generation is a durable prerequisite for scaling operations, validating product-market fit and enabling progressive margin improvement if scaled.

Positive short-term growth indicators

Reported revenue and EPS growth metrics point to an improving operational trajectory. If these trends persist beyond transient effects, they can signal underlying business model progress, helping to reduce losses and improve fundamentals over a multi-month horizon as scaling effects kick in.

Negative Factors

Severe cash burn

Material negative operating and free cash flow indicate the company is consuming cash rather than generating it, creating a structural reliance on external funding. Persistent cash burn threatens runway, raises refinancing or dilution risk, and constrains investment in growth over coming months.

Deep and persistent losses

Large negative gross and net margins show the core business is loss-making at scale. Continued heavy operating losses imply the current business model has not achieved unit economics; absent significant structural changes, profitability is unlikely within a multi-month timeframe.

Negative returns and equity volatility

Extremely poor returns on equity and a history of distorted/negative equity signal capital destruction and volatile balance-sheet metrics. This undermines investor confidence and can materially impair the company's ability to secure patient capital or favorable financing terms over the medium term.

Nur Business Overview & Revenue Model

Company Description

Nur Ink Innovations Ltd engages in the design, development, production, and sale water-based pigmented inks for digital inkjet printing applications in Israel. It offers Digital Sol-Gel, a water-based pigment inks for digital printing; and white water-based pigment dispersion and functional inks for various applications, markets, and technologies. The company was founded in 2018 and is based in Rosh HaAyin, Israel.

How the Company Makes Money

Nur Financial Statement Overview

Summary

Overall financial profile is high-risk: severe negative margins and sizable net losses persist, and cash flow shows material ongoing cash burn (negative operating and free cash flow). The balance sheet is a relative positive with low debt-to-equity and positive equity, but returns are deeply negative, indicating continuing pressure on capital.

Income Statement

Profitability is very weak: 2024 revenue was only 253k while gross profit was -2.69M, resulting in deeply negative gross margin (-10.6%) and heavy operating losses (EBIT margin -36.8%, EBITDA margin -29.9%). While 2024 shows revenue appearing after several years of zero reported revenue and a high growth rate off a very low base, losses remain large (net income -9.67M; net margin -38.2%), indicating the business has not yet demonstrated a viable earnings model.

Balance Sheet

Leverage looks manageable on the surface: 2024 debt-to-equity is low (~0.21) with equity of 12.83M versus debt of 2.70M, which provides some balance-sheet flexibility. However, returns are extremely poor (2024 return on equity about -75%), reflecting significant value erosion from ongoing losses; prior years also show highly volatile and distorted equity/return figures (including negative equity in 2020), which raises confidence and stability concerns.

Cash Flow

Cash generation is strained. In 2024, operating cash flow was -6.61M and free cash flow was -7.13M, indicating the company is consuming cash rather than funding itself internally. Free cash flow also deteriorated sharply versus the prior year (large negative growth), suggesting rising cash needs; while free cash flow is roughly in line with (and slightly less negative than) net income, the overall picture points to continued dependence on external financing or capital raises.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	186.00K	253.00K	0.00	0.00	0.00	0.00
Gross Profit	-3.21M	-2.69M	-1.72M	-84.00	-137.00	-146.00
EBITDA	-6.20M	-7.56M	-11.35K	-10.18M	-7.07M	-3.04M
Net Income	-8.31M	-9.66M	-12.86M	-11.61M	-7.78M	-4.05M
Balance Sheet
Total Assets	14.09M	18.39M	21.83K	33.29K	41.07K	1.32K
Cash, Cash Equivalents and Short-Term Investments	940.00K	5.63M	10.44K	21.33K	32.90K	183.00
Total Debt	2.43M	2.70M	2.70K	3.12K	3.51K	1.35K
Total Liabilities	5.15M	5.56M	5.76K	5.48K	5.28K	2.36K
Stockholders Equity	8.94M	12.83M	16.08K	27.80K	35.80K	-1.03K
Cash Flow
Free Cash Flow	-7.02M	-7.13M	-10.17K	-8.09K	-9.12K	-2.66K
Operating Cash Flow	-6.84M	-6.61M	-9.32K	-6.27K	-6.34K	-2.44K
Investing Cash Flow	8.87M	418.00K	485.00	-14.40K	-3.31K	-172.00
Financing Cash Flow	-2.33M	5.22M	-447.00	-385.00	42.39K	2.06K

Nur Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
Sector *	61 Neutral	$37.18B	12.37	-10.20%	1.83%	8.50%	-7.62%
MSVT	52 Neutral	₪28.72M	-0.48	―	―	-42.73%	11.43%
NURI	50 Neutral	₪79.12M	-7.08	―	―	―	―
ZOOZ	42 Neutral	₪194.28M	-0.30	―	―	36.26%	43.84%
NRGN	40 Underperform	₪34.22M	-3.02	―	―	-23.68%	31.97%